Podcast

Podcast Series Episode 3: Beyond Buzzwords - Have Decentralized Clinical Trials Become The New Norm?

Episode 3 of  "Through the Biotech Lens: Molecule to Market" features Jerome Armellini and Dr. Craig Underhill as they delve into how the COVID-19 pandemic has accelerated the adoption of decentralized clinical trials. Learn about the benefits of these decentralized trials and how IQVIA's technology platforms brings the decentralized solution to life and benefits patients directly.

access the Podcast!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

IQVIA Biotech